Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease.
- DOI
- 10.1016/j.ejphar.2026.179320
- Published
- 2026 Oct 28
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179320,
title = {Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease.},
author = {Han Z and Liu W and Fu W and Wang K and Tan Z and Zhang D and Yang F and Dong W and Sang Z},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179320},
url = {https://doi.org/10.1016/j.ejphar.2026.179320}
}RIS
TY - JOUR TI - Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease. AU - Han Z AU - Liu W AU - Fu W AU - Wang K AU - Tan Z AU - Zhang D AU - Yang F AU - Dong W AU - Sang Z PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179320 UR - https://doi.org/10.1016/j.ejphar.2026.179320 ER -
APA
Z, H., W, L., W, F., K, W., Z, T., D, Z., F, Y., W, D., & Z, S. (2026). Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179320
Source records
- pubmed · retrieved 2026-09-25T23:44:03.704Z